Sponsors / CMPS
CMPS

COMPASS Pathways

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
7Trials in this database
9Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant DepressionNCT04739865COMPASS PathwaysPhase 2Completed2021-10-14Actual
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT05312151COMPASS PathwaysPhase 2Completed2024-02-12Actual
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyNCT05481736COMPASS PathwaysPhase 2Completed2024-11-18Actual
Efficacy, Safety, and Tolerability of COMP360 in Participants With TRDNCT05624268COMPASS PathwaysPhase 3Completed2025-05-28Actual
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940COMPASS PathwaysPhase 3Active not recruiting2025-11-13Actual
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderNCT05733546COMPASS PathwaysPhase 2Active not recruiting2025-09Estimated
Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT07570654COMPASS PathwaysPhase 2, Phase 3Recruiting2028-11Estimated

Latest recorded trial changes